RVLP - GAAP EPS of -$0.08 beats by $0.13 revenue of $21.4M beats by $14.6M May, 12 2022 06:52 AM RVL Pharmaceuticals plc press release (NASDAQ:RVLP): Q1 GAAP EPS of -$0.08 beats by $0.13. Revenue of $21.4M beats by $14.6M. For further details see: GAAP EPS of -$0.08 beats by $0.13, revenue of $21.4M beats by $14.6M